{"DataElement":{"publicId":"5076051","version":"1","preferredName":"Agent Prior Anthracycline Exposure Administered Dose","preferredDefinition":"Information related to the prior anthracycline dose administered.","longName":"AgtPrAnthExpAdmDs","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5076013","version":"1","preferredName":"Agent Prior Anthracycline Antineoplastic Antibiotic Exposure Administered","preferredDefinition":"Information related to an active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. Earlier in time or order. A type of antibiotic that comes from certain types of Streptomyces bacteria. Anthracyclines are used to treat many types of cancer. The act of subjecting someone or something to an influencing experience. The act of having given something (e.g., a medication or test).","longName":"2223333v1.0:5076011v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2223333","version":"1","preferredName":"Agent","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B10F2-76A7-2830-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5076011","version":"1","preferredName":"Prior Anthracycline Antineoplastic Antibiotic Exposure Administered","preferredDefinition":"Earlier in time or order.:A type of antibiotic that comes from certain types of Streptomyces bacteria. Anthracyclines are used to treat many types of cancer. Anthracyclines damage the DNA in cancer cells, causing them to die. Daunorubicin, doxorubicin, and epirubicin are anthracyclines.:The act of subjecting someone or something to an influencing experience.:The act of having given something (e.g., a medication or test).","longName":"C25629:C1594:C17941:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Anthracycline Antineoplastic Antibiotic","conceptCode":"C1594","definition":"An antineoplastic antibiotic that is structurally similar to the benzoquinone ansamycin antibiotic geldanamycin. A geldanamycin analogue binds to HSP90, a chaperone protein that aids in the assembly, maturation, and folding of proteins. Subsequently, the function of HSP90 is inhibited, leading to the degradation and depletion of client proteins such as kinases and transcription factors involved with cell cycle regulation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Exposure","conceptCode":"C17941","definition":"The act of subjecting someone or something to an influencing experience.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"261E1F1C-71AB-3348-E050-BB89AD435565","latestVersionIndicator":"Yes","beginDate":"2015-12-04","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-04","modifiedBy":"ONEDATA","dateModified":"2015-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008572","version":"1","preferredName":"test","preferredDefinition":"test","longName":"TEST","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"BB0B9356-4C1D-6337-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-11","endDate":"2021-11-16","createdBy":"JASUR","dateCreated":"2003-04-11","modifiedBy":"TAYLORT","dateModified":"2021-11-17","changeDescription":"11/17/21 changed WS from Retired Deleted to Retired Archived and added end date. Workflow status set to \"Retired Deleted\" in 3.0 deployment, was previously Deleted using the Admin Tool \"Delete\" function key. This function is no longer available.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"261E1F1C-71BC-3348-E050-BB89AD435565","latestVersionIndicator":"Yes","beginDate":"2015-12-04","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5076031","version":"1","preferredName":"Dose","preferredDefinition":"Information related to a quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"5076031v1.0","context":"COG","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"mg/m2","minLength":"1","maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":null,"format":"999.9","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2432127","version":"1","preferredName":"Dose","preferredDefinition":"The amount of medicine taken, or radiation given, at one time.","longName":"C25488","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"061284D5-1977-0705-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-11-21","modifiedBy":"ONEDATA","dateModified":"2005-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"261E5FD8-C58D-B0FE-E050-BB89AD4311BA","latestVersionIndicator":"Yes","beginDate":"2015-12-04","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-04","modifiedBy":"MIRANDAA","dateModified":"2016-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Cumulative prior Anthracyclin","type":"Preferred Question Text","description":"Cumulative prior Anthracycline exposure daunorubicin equivalent?","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"What is the cumulative Idarubicin exposure?","url":null,"context":"COG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"What is the cumulative exposure of other anthracycline?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"What is the cumulative Mitoxantrone exposure?","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"What is the cumulative CPX-351 exposure based on Daunorubicin dose?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"261E5FD8-C5AA-B0FE-E050-BB89AD4311BA","latestVersionIndicator":"Yes","beginDate":"2015-12-04","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-04","modifiedBy":"KUMMEROA","dateModified":"2023-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}